Barinthus Biotherapeutics Plc ADR (BRNS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,852 | 75,674 | 87,784 | 100,579 | 112,400 |
| Receivables | 1,108 | 4,633 | 4,536 | 2,997 | 7,139 |
| Other current assets | 0 | 138 | 413 | 0 | 0 |
| TOTAL | $77,790 | $86,781 | $100,414 | $109,882 | $125,742 |
| Non-Current Assets | |||||
| PPE Net | 3,523 | 4,519 | 4,514 | 6,201 | 7,373 |
| Intangibles | 14,288 | 14,909 | 20,366 | 21,156 | 21,947 |
| Other Non-Current Assets | 2,568 | 2,992 | 4,267 | 4,757 | 5,265 |
| TOTAL | $20,379 | $22,420 | $29,147 | $32,114 | $34,585 |
| Total Assets | $98,169 | $109,201 | $129,561 | $141,996 | $160,327 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 350 | 698 | 1,800 | 1,357 | 2,474 |
| Accrued Expenses | 6,249 | 6,681 | 7,364 | 7,198 | 9,525 |
| TOTAL | $10,018 | $10,798 | $12,725 | $11,976 | $15,657 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,396 | 1,402 | 1,525 | 1,461 | 1,738 |
| Other Non-Current Liabilities | 13,618 | 13,527 | 13,966 | 14,021 | 14,148 |
| TOTAL | $13,859 | $13,842 | $14,355 | $14,427 | $14,535 |
| Total Liabilities | $23,877 | $24,640 | $27,080 | $26,403 | $30,192 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 40,830 | 40,718 | 40,339 | 40,339 |
| Common Shares | 87 | 87 | 87 | 87 | 87 |
| Retained earnings | -304,092 | -293,002 | -278,436 | -257,312 | -237,664 |
| Other shareholders' equity | -15,647 | -15,772 | -12,833 | -21,126 | -25,762 |
| TOTAL | $74,292 | $84,561 | $102,481 | $115,593 | $130,135 |
| Total Liabilities And Equity | $98,169 | $109,201 | $129,561 | $141,996 | $160,327 |